Polymorphisms of COMT and XPD and risk of esophageal squamous cell carcinoma in a population of Yili Prefecture, in Xinjiang, China

References

• Affatato AA, Wolfe KJ, Lopez MS, Hallberg C, Ammenheuser MM, Abdel-Rahman SZ. (2004). Effect of XPD/ERCC2 polymorphisms on chromosome aberration frequencies in smokers and on sensitivity to the mutagenic tobacco-specific nitrosamine NNK. Environ Mol Mut 44:65–73.
   PubMedGoogle Scholar
• Benhamou S, Sarasin A. (2002). ERCC2/XPD gene polymorphisms and cancer risk. Mutagenesis 17:463–9.
   PubMed Web of Science ®Google Scholar
• Berwick M, Vineis P. (2000). Markers of DNA repair and susceptibility to cancer in humans: an epidemiologic review. J Natl Cancer Inst 92:874–97.
   PubMed Web of Science ®Google Scholar
• Boer JG. (2002). Polymorphisms in DNA repair and environmental interactions. Mutat Res 509:201–10.
   PubMedGoogle Scholar
• Cavalieri E, Frenkel K, Liehr J, Rogan E, Roy D. (2000). Oestrogens as endogenous genotoxic agents – DNA adducts and mutations. J Natl Cancer Inst 27:75–93.
   Google Scholar
• Cavalieri E, Stack D, Devanesan P, Todorovic R, Dwivedy I, Higginbotham S, Johansson S, Patil K, Gross M, Gooden J, Ramanathan R, Cerny R, Rogan E. (1997). Molecular origin of cancer: catechol oestrogen-3,4-quinones as endogenous tumour initiators. Proc Nat Acad Sci 94:10937–42.
   PubMed Web of Science ®Google Scholar
• Creveling CR, Inoue K. (1994). Catechol-O-methyltransferase: factors relating to the carcinogenic potential of catechol estrogens. Polycyclic Aromatic Compounds 6:253–9.
   Google Scholar
• Dawling S, Roodi N, Mernaugh RL, Wang X, Parl FF. (2001). Catechol-O-methyltransferase (COMT)-mediated metabolism of catechol estrogens: comparison of wild-type and variant COMT isoforms. Cancer Res 61:6716–22.
   PubMed Web of Science ®Google Scholar
• Flores-Obando RE, Gollin SM, Ragin CC. (2010). Polymorphisms in DNA damage response genes and head and neck cancer risk. Biomarkers 15:379–99.
   PubMed Web of Science ®Google Scholar
• Huang CS, Chern HD, Chang KJ, Cheng CW, Hsu SM, Shen CY. (1999). Breast cancer risk associated with genotype polymorphism of the estrogen-metabolizing genes CYP17, CYP1A1, and COMT: a multigenic study on cancer susceptibility. Cancer Res 59:4870–5.
   PubMed Web of Science ®Google Scholar
• Jemal A, Murray T, Ward E, Samuels A, Tiwari RC, Ghafoor A, Feuer EJ, Thun MJ. (2005). Cancer statistics, 2005. CA Cancer J Clin 55:302–10.
   Google Scholar
• Kunugi H, Nanko S, Ueki. (1997). High and low activity alleles of catechol-O-methyltransferase gene: ethnic difference and possible association with Parkinson’s disease. Neurosci Lett 221:202–4.
   PubMed Web of Science ®Google Scholar
• Laine JP, Mocquet V, Bonfanti M, Braun C, Egly JM, Brousset P. (2007). Common XPD (ERCC2) polymorphisms have no measurable effect on nucleotide excision repair and basal transcription. DNA Repair 6:1264–70.
   PubMedGoogle Scholar
• Lambert R, Hainaut P. (2007). The multidisciplinary management of gastrointestinal cancer: Epidemiology of oesophagogastric cancer. Best Pract Res Clin Gastroenterol 21:921–45.
   PubMed Web of Science ®Google Scholar
• Lu JB, Yang WX, Liu JM, Li YS, Qin YM. (1985).Trends in morbidity and mortality for oesophageal cancer in Linxian County 1959–1983. Int J Cancer 36:643–5.
   PubMedGoogle Scholar
• Manuguerra M, Saletta F, Karagas MR, Berwick M, Veglia F, Vineis P, Matullo G. (2006). XRCC3 and XPD/ERCC2 single nucleotide polymorphisms and the risk of cancer: a HUGE review. Am J Epidemiol 164:297–302.
   PubMed Web of Science ®Google Scholar
• Miller SA, Dybes DD, Polesky HF. (1988).A simple salting out procedure for extracting DNA from human nucleated cells. Nucl Acids Res 16:1215–19.
   PubMed Web of Science ®Google Scholar
• Millikan RC, Pittman GS, Tse CK, Duell E, Newman B, Savitz D, Moorman PG, Boissy RJ, Bell DA. (1998). Catechol-O-methyltransferase and breast cancer risk. Carcinogenesis 19: 1943–1947.
   PubMed Web of Science ®Google Scholar
• Rzeszowska-Wolny J, Polanska J, Pietrowska M, Palyvoda O, Jaworsk J, Butkiewicz D, Hancock R. (2005). Influence of polymorphisms in DNA repair genes XPD, XRCC1 and MGMT on DNA damage induced by gamma radiation and its repair in lymphocytes in vitro. Radiation Res 164:132–40.
   PubMed Web of Science ®Google Scholar
• Shen MR, Jones IM, Mohrenweiser H. (1998). Non conservative amino acid substitution variants exist at polymorphic frequency DNA repair genes in healthy humans. Cancer Res 58:604–8.
   PubMed Web of Science ®Google Scholar
• Spitz MR, Wu X, Wang Y, Wang LE, Shete S, Amos CI, Guo Z, Lei L, Mohrenweiser H. Wei Q. (2001). Modulation of nucleotide excision repair capacity by XPD polymorphisms in lung cancer patients. Cancer Res 61:1354–7.
   PubMed Web of Science ®Google Scholar
• Stewart BW, Kleihues P. (2003). World Cancer Report. Lyon: IARC Press. p. 223–7.
   Google Scholar
• Syvanen AC, Tilgmann C, Rinne J, Ulmanen I. (1997). Genetic polymorphism of catechol-O-methyltransferase (COMT): correlation of genotype with individual variation of S-COMT activity and comparison of the allele frequencies in the normal population and parkinsonian patients in Finland. Pharmacogenetics 7:65–71.
   PubMedGoogle Scholar
• Thompson PA, Shields PG, Freudenheim JL, Stone A, Vena JE, Marshall JR, Graham S, Laughlin R, Nemoto T, Kadlubar FF, Ambrosone CB. (1998). Genetic polymorphisms in catechol-O-methyltransferase, menopausal status, and breast cancer risk. Cancer Res 58:2107–10.
   PubMed Web of Science ®Google Scholar
• Vineis P, Manuguerra M, Kavvoura FK, Guarrera S, Allione A, Rosa F, Di Gregorio A, Polidoro S, Saletta F, Ioannidis JP, Matullo G. (2009). A field synopsis on low-penetrance variants in DNA repair genes and cancer susceptibility. J Natl Cancer Inst 101:24–36.
   PubMedGoogle Scholar
• Wang F, Chang D, Hu FI, Sui H, Han B, li DD, Zhao YS. (2008). DNA repair gene XPD polymorphisms and cancer risk: a meta-analysis based on 56 case–control studies. Cancer Epidemiol Biomarkers Prev 17:507–17.
   PubMed Web of Science ®Google Scholar
• Wood RD. (1999). DNA damage recognition during nucleotide excision repair in mammalian cells. Biochimie 81:39–44.
   PubMed Web of Science ®Google Scholar
• Yager JD. (2000). Chapter 3: endogenous estrogens as carcinogens through metabolic activation. J Natl Cancer Inst 27:67–73.
   Google Scholar
• Zhang YM. (1988). The distribution of esophageal cancer in Xinjiang. Xinjiang Yixueyuan Xuebao 11:139–44.
   Google Scholar